Antioxidants and zinc to prevent progression of age-related macular degeneration

Journal of the American Medical Association

Volumn 286, Issue 19, 2001, Pages 2466-2468

  Jampol, Lee M ^a   Ferris, F L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; PLACEBO; ZINC;

ADULT; AGED; AGING; ANTIOXIDANT ACTIVITY; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RISK FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; VITAMIN INTAKE;

EID: 0035930105     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.19.2466     Document Type: Note

References (10)

1. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Study
2. Use of eye care services among the 1991 Medicare population
3. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8
4. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9
5. The linxian cataract studies: Two nutritional intervention trials
6. Long-term supplementation with alpha-tocopherol and beta-carotene and age-related cataract
7. Beta-carotene and age-related cataract in a randomized trial of U.S. Physicians
8. VECAT study: The effect of vitamin E on the progression of lens opacities: Preliminary results
9. Antioxidants, zinc, and age-related macular degeneration: Results and recommendations